» Articles » PMID: 18556627

Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1

Overview
Specialty Critical Care
Date 2008 Jun 17
PMID 18556627
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Oxidative stress is a key contributor in chronic obstructive pulmonary disease (COPD) pathogenesis caused by cigarette smoking. NRF2, a redox-sensitive transcription factor, dissociates from its inhibitor, KEAP1, to induce antioxidant expression that inhibits oxidative stress.

Objectives: To determine the link between severity of COPD, oxidative stress, and NRF2-dependent antioxidant levels in the peripheral lung tissue of patients with COPD.

Methods: We assessed the expression of NRF2, NRF2-dependent antioxidants, regulators of NRF2 activity, and oxidative damage in non-COPD (smokers and former smokers) and smoker COPD lungs (mild and advanced). Cigarette smoke-exposed human lung epithelial cells (Beas2B) and mice were used to understand the mechanisms.

Measurements And Main Results: When compared with non-COPD lungs, the COPD patient lungs showed (1) marked decline in NRF2-dependent antioxidants and glutathione levels, (2) increased oxidative stress markers, (3) significant decrease in NRF2 protein with no change in NRF2 mRNA levels, and (4) similar KEAP1 but significantly decreased DJ-1 levels (a protein that stabilizes NRF2 protein by impairing KEAP1-dependent proteasomal degradation of NRF2). Exposure of Bea2B cells to cigarette smoke caused oxidative modification and enhanced proteasomal degradation of DJ-1 protein. Disruption of DJ-1 in mouse lungs, mouse embryonic fibroblasts, and Beas2B cells lowered NRF2 protein stability and impaired antioxidant induction in response to cigarette smoke. Interestingly, targeting KEAP1 by siRNA or the small-molecule activator sulforaphane restored induction of NRF2-dependent antioxidants in DJ-1-disrupted cells in response to cigarette smoke.

Conclusions: NRF2-dependent antioxidants and DJ-1 expression was negatively associated with severity of COPD. Therapy directed toward enhancing NRF2-regulated antioxidants may be a novel strategy for attenuating the effects of oxidative stress in the pathogenesis of COPD.

Citing Articles

The Role of Astrocytic Mitochondria in the Pathogenesis of Brain Ischemia.

Zhang L, Hu Y, Liu X, Wang X, Li S, Zhang J Mol Neurobiol. 2023; 61(4):2270-2282.

PMID: 37870679 DOI: 10.1007/s12035-023-03714-z.


How to Increase Cellular Glutathione.

Giustarini D, Milzani A, Dalle-Donne I, Rossi R Antioxidants (Basel). 2023; 12(5).

PMID: 37237960 PMC: 10215789. DOI: 10.3390/antiox12051094.


Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease.

Fairley L, Das S, Dharwal V, Amorim N, Hegarty K, Wadhwa R Antioxidants (Basel). 2023; 12(4).

PMID: 37107348 PMC: 10135688. DOI: 10.3390/antiox12040973.


Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease.

Arezina R, Chen T, Wang D Int J Chron Obstruct Pulmon Dis. 2023; 18:447-457.

PMID: 37038544 PMC: 10082417. DOI: 10.2147/COPD.S393540.


Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries.

Bezerra F, Lanzetti M, Nesi R, Nagato A, Silva C, Kennedy-Feitosa E Antioxidants (Basel). 2023; 12(3).

PMID: 36978796 PMC: 10045332. DOI: 10.3390/antiox12030548.


References
1.
Rangasamy T, Guo J, Mitzner W, Roman J, Singh A, Fryer A . Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005; 202(1):47-59. PMC: 2212893. DOI: 10.1084/jem.20050538. View

2.
Yanagisawa D, Kitamura Y, Inden M, Takata K, Taniguchi T, Morikawa S . DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab. 2007; 28(3):563-78. DOI: 10.1038/sj.jcbfm.9600553. View

3.
Rahman I, van Schadewijk A, Crowther A, Hiemstra P, Stolk J, MacNee W . 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166(4):490-5. DOI: 10.1164/rccm.2110101. View

4.
Thimmulappa R, Mai K, Srisuma S, Kensler T, Yamamoto M, Biswal S . Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002; 62(18):5196-203. View

5.
Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T . Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005; 175(10):6968-75. DOI: 10.4049/jimmunol.175.10.6968. View